BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Massi M, Ciccocioppo R. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 2009;34:2125-34. [PMID: 19322167 DOI: 10.1038/npp.2009.37] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Boeck CR, Martinello C, de Castro AA, Moretti M, dos Santos Casagrande T, Guerrini R, Calo’ G, Gavioli EC. Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice. Naunyn-Schmied Arch Pharmacol 2010;381:153-60. [DOI: 10.1007/s00210-009-0480-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
2 Peng YL, Han RW, Chang M, Zhang L, Zhang RS, Li W, Han YF, Wang R. Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor. Peptides 2010;31:2259-63. [PMID: 20800637 DOI: 10.1016/j.peptides.2010.08.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
3 Cannella N, Ubaldi M, Masi A, Bramucci M, Roberto M, Bifone A, Ciccocioppo R. Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neurosci Biobehav Rev 2019;103:384-98. [PMID: 31112713 DOI: 10.1016/j.neubiorev.2019.05.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
4 Cannella N, Kallupi M, Li HW, Stopponi S, Cifani C, Ciccocioppo R, Ubaldi M. Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats. Psychopharmacology (Berl) 2016;233:2915-24. [PMID: 27235017 DOI: 10.1007/s00213-016-4333-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
5 Ruggeri B, Braconi S, Cannella N, Kallupi M, Soverchia L, Ciccocioppo R, Ubaldi M. Neuropeptide S receptor gene expression in alcohol withdrawal and protracted abstinence in postdependent rats. Alcohol Clin Exp Res 2010;34:90-7. [PMID: 19860802 DOI: 10.1111/j.1530-0277.2009.01070.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
6 Ubaldi M, Bifone A, Ciccocioppo R. Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides. Curr Opin Neurobiol 2013;23:684-91. [PMID: 23648086 DOI: 10.1016/j.conb.2013.04.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
7 Yaeger JD, Krupp KT, Gale JJ, Summers CH. Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery 2020;8:100059. [DOI: 10.1016/j.medidd.2020.100059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zoicas I, Menon R, Neumann ID. Neuropeptide S reduces fear and avoidance of con-specifics induced by social fear conditioning and social defeat, respectively. Neuropharmacology 2016;108:284-91. [PMID: 27044664 DOI: 10.1016/j.neuropharm.2016.03.054] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
9 Cao J, de Lecea L, Ikemoto S. Intraventricular administration of neuropeptide S has reward-like effects. Eur J Pharmacol 2011;658:16-21. [PMID: 21349268 DOI: 10.1016/j.ejphar.2011.02.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
10 Greenwald MK. Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework. Neurobiol Stress 2018;9:84-104. [PMID: 30238023 DOI: 10.1016/j.ynstr.2018.08.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
11 McDonald AJ, Alonso-Lozares I, Rauh V, van Mourik Y, Schetters D, De Vries TJ, Marchant NJ. Alcohol Seeking Under Risk of Punishment Is Associated With Activation of Cortical and Subcortical Brain Regions. Front Behav Neurosci 2021;15:739681. [PMID: 34744653 DOI: 10.3389/fnbeh.2021.739681] [Reference Citation Analysis]
12 Ubaldi M, Giordano A, Severi I, Li H, Kallupi M, de Guglielmo G, Ruggeri B, Stopponi S, Ciccocioppo R, Cannella N. Activation of Hypocretin-1/Orexin-A Neurons Projecting to the Bed Nucleus of the Stria Terminalis and Paraventricular Nucleus Is Critical for Reinstatement of Alcohol Seeking by Neuropeptide S. Biol Psychiatry 2016;79:452-62. [PMID: 26055195 DOI: 10.1016/j.biopsych.2015.04.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
13 Zhang H, Lian Z, Yan S, Bao Y, Liu Z. Different levels in orexin concentrations and risk factors associated with higher orexin levels: comparison between detoxified opiate and methamphetamine addicts in 5 Chinese cities. Biomed Res Int 2013;2013:282641. [PMID: 24102051 DOI: 10.1155/2013/282641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 2012;198:79-121. [PMID: 22813971 DOI: 10.1016/B978-0-444-59489-1.00007-0] [Cited by in Crossref: 140] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
15 Blough B, Namjoshi O. Small Molecule Neuropeptide S and Melanocortin 4 Receptor Ligands as Potential Treatments for Substance Use Disorders. Handb Exp Pharmacol 2020;258:61-87. [PMID: 31628605 DOI: 10.1007/164_2019_313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Ubaldi M, Cannella N, Ciccocioppo R. Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics. Prog Brain Res 2016;224:251-84. [PMID: 26822362 DOI: 10.1016/bs.pbr.2015.07.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
17 Pałasz A, Żarczyński P, Bogus K, Mordecka-Chamera K, Della Vecchia A, Skałbania J, Worthington JJ, Krzystanek M, Żarczyńska M. Modulatory effect of olanzapine on SMIM20/phoenixin, NPQ/spexin and NUCB2/nesfatin-1 gene expressions in the rat brainstem. Pharmacol Rep 2021;73:1188-94. [PMID: 33928538 DOI: 10.1007/s43440-021-00267-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Valsalan R, Manoj N. Evolutionary history of the neuropeptide S receptor/neuropeptide S system. Gen Comp Endocrinol 2014;209:11-20. [PMID: 24859256 DOI: 10.1016/j.ygcen.2014.05.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
19 Pfarr S, Meinhardt MW, Klee ML, Hansson AC, Vengeliene V, Schönig K, Bartsch D, Hope BT, Spanagel R, Sommer WH. Losing Control: Excessive Alcohol Seeking after Selective Inactivation of Cue-Responsive Neurons in the Infralimbic Cortex. J Neurosci 2015;35:10750-61. [PMID: 26224858 DOI: 10.1523/JNEUROSCI.0684-15.2015] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 8.9] [Reference Citation Analysis]
20 Shalev U, Erb S, Shaham Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 2010;1314:15-28. [PMID: 19631614 DOI: 10.1016/j.brainres.2009.07.028] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
21 Kenny PJ. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 2011;97:700-7. [PMID: 20816891 DOI: 10.1016/j.pbb.2010.08.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
22 Albanese V, Ruzza C, Marzola E, Bernardi T, Fabbri M, Fantinati A, Trapella C, Reinscheid RK, Ferrari F, Sturaro C, Calò G, Amendola G, Cosconati S, Pacifico S, Guerrini R, Preti D. Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity. J Med Chem 2021;64:4089-108. [PMID: 33733768 DOI: 10.1021/acs.jmedchem.0c02223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Cifani C, Micioni Di Bonaventura MV, Cannella N, Fedeli A, Guerrini R, Calo G, Ciccocioppo R, Ubaldi M. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat. Peptides 2011;32:44-50. [PMID: 20971145 DOI: 10.1016/j.peptides.2010.10.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
24 Lawrence AJ. Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res 2010;1314:124-9. [PMID: 19646424 DOI: 10.1016/j.brainres.2009.07.072] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
25 Liu X, Zeng J, Zhou A, Theodorsson E, Fahrenkrug J, Reinscheid RK. Molecular fingerprint of neuropeptide S-producing neurons in the mouse brain. J Comp Neurol 2011;519:1847-66. [PMID: 21452230 DOI: 10.1002/cne.22603] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
26 Young CE, Tong Q. Corticotropin Releasing Hormone Signaling in the Bed Nuclei of the Stria Terminalis as a Link to Maladaptive Behaviors. Front Neurosci 2021;15:642379. [PMID: 33867924 DOI: 10.3389/fnins.2021.642379] [Reference Citation Analysis]
27 Reinscheid RK, Ruzza C. Pharmacology, Physiology and Genetics of the Neuropeptide S System. Pharmaceuticals (Basel) 2021;14:401. [PMID: 33922620 DOI: 10.3390/ph14050401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lerma-Cabrera JM, Carvajal F, Alcaraz-Iborra M, de la Fuente L, Navarro M, Thiele TE, Cubero I. Adolescent binge-like ethanol exposure reduces basal α-MSH expression in the hypothalamus and the amygdala of adult rats. Pharmacol Biochem Behav 2013;110:66-74. [PMID: 23792540 DOI: 10.1016/j.pbb.2013.06.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
29 Guerrini R, Salvadori S, Rizzi A, Regoli D, Calo' G. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Med Res Rev 2010;30:751-77. [PMID: 19824051 DOI: 10.1002/med.20180] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 6.6] [Reference Citation Analysis]
30 Ruzza C, Rizzi A, Trapella C, Pela' M, Camarda V, Ruggieri V, Filaferro M, Cifani C, Reinscheid RK, Vitale G, Ciccocioppo R, Salvadori S, Guerrini R, Calo' G. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. Peptides 2010;31:915-25. [PMID: 20172007 DOI: 10.1016/j.peptides.2010.02.012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
31 Pacheco R, Pescador BB, Mendonça BP, Ramos SF, Guerrini R, Calo' G, de Andrade VM, Gavioli EC, Boeck CR. Role of the ecto-nucleotidases in the cooperative effect of adenosine and neuropeptide-S on locomotor activity in mice. Pharmacol Biochem Behav 2011;99:726-30. [PMID: 21741987 DOI: 10.1016/j.pbb.2011.06.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
32 Cubero I, Navarro M, Carvajal F, Lerma-Cabrera JM, Thiele TE. Ethanol-induced increase of agouti-related protein (AgRP) immunoreactivity in the arcuate nucleus of the hypothalamus of C57BL/6J, but not 129/SvJ, inbred mice. Alcohol Clin Exp Res 2010;34:693-701. [PMID: 20102560 DOI: 10.1111/j.1530-0277.2009.01138.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
33 Fendt M, Buchi M, Bürki H, Imobersteg S, Ricoux B, Suply T, Sailer AW. Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response. Behav Brain Res 2011;217:1-9. [PMID: 20888368 DOI: 10.1016/j.bbr.2010.09.022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
34 Perry CJ, Zbukvic I, Kim JH, Lawrence AJ. Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol 2014;171:4636-72. [PMID: 24749941 DOI: 10.1111/bph.12735] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
35 Enquist J, Ferwerda M, Madhavan A, Hok D, Whistler JL. Chronic ethanol potentiates the effect of neuropeptide s in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects. Neuropsychopharmacology 2012;37:2436-45. [PMID: 22739468 DOI: 10.1038/npp.2012.102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
36 Thorsell A, Tapocik JD, Liu K, Zook M, Bell L, Flanigan M, Patnaik S, Marugan J, Damadzic R, Dehdashti SJ, Schwandt ML, Southall N, Austin CP, Eskay R, Ciccocioppo R, Zheng W, Heilig M. A novel brain penetrant NPS receptor antagonist, NCGC00185684, blocks alcohol-induced ERK-phosphorylation in the central amygdala and decreases operant alcohol self-administration in rats. J Neurosci 2013;33:10132-42. [PMID: 23761908 DOI: 10.1523/JNEUROSCI.4742-12.2013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
37 Martin-fardon R, Weiss F. Modeling Relapse in Animals. In: Sommer WH, Spanagel R, editors. Behavioral Neurobiology of Alcohol Addiction. Berlin: Springer Berlin Heidelberg; 2013. pp. 403-32. [DOI: 10.1007/978-3-642-28720-6_202] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
38 Ghazal P, Corsi M, Roth A, Faggioni F, Corti C, Merlo Pick E, Pucciarelli S, Ciccocioppo R, Ubaldi M. Paradoxical response to the sedative effects of diazepam and alcohol in C57BL/6J mice lacking the neuropeptide S receptor. Peptides 2014;61:107-13. [PMID: 25240770 DOI: 10.1016/j.peptides.2014.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Castro A, Casagrande T, Moretti M, Constantino L, Petronilho F, Guerra G, Calo’ G, Guerrini R, Dal-pizzol F, Quevedo J, Gavioli E. Lithium attenuates behavioral and biochemical effects of neuropeptide S in mice. Peptides 2009;30:1914-20. [DOI: 10.1016/j.peptides.2009.07.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
40 Liu X, Si W, Garau C, Jüngling K, Pape HC, Schulz S, Reinscheid RK. Neuropeptide S precursor knockout mice display memory and arousal deficits. Eur J Neurosci 2017;46:1689-700. [PMID: 28548278 DOI: 10.1111/ejn.13613] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
41 Ch'ng S, Fu J, Brown RM, Mcdougall SJ, Lawrence AJ. The intersection of stress and reward: BNST modulation of aversive and appetitive states. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;87:108-25. [DOI: 10.1016/j.pnpbp.2018.01.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 11.8] [Reference Citation Analysis]
42 Chou YH, Hor CC, Lee MT, Lee HJ, Guerrini R, Calo G, Chiou LC. Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid. Addict Biol 2021;26:e12971. [PMID: 33078457 DOI: 10.1111/adb.12971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Kim AK, Brown RM, Lawrence AJ. The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship. Front Behav Neurosci 2012;6:78. [PMID: 23189046 DOI: 10.3389/fnbeh.2012.00078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
44 Walker LC, Ch’ng SS, Lawrence AJ. Role of Lateral Hypothalamic Orexin (Hypocretin) Neurons in Alcohol Use and Abuse: Recent Advances. Curr Pharmacol Rep 2016;2:241-52. [DOI: 10.1007/s40495-016-0069-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Reinscheid RK, Mafessoni F, Lüttjohann A, Jüngling K, Pape HC, Schulz S. Neandertal introgression and accumulation of hypomorphic mutations in the neuropeptide S (NPS) system promote attenuated functionality. Peptides 2021;138:170506. [PMID: 33556445 DOI: 10.1016/j.peptides.2021.170506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
46 Ruzza C, Calò G, Di Maro S, Pacifico S, Trapella C, Salvadori S, Preti D, Guerrini R. Neuropeptide S receptor ligands: a patent review (2005-2016). Expert Opin Ther Pat 2017;27:347-62. [PMID: 27788040 DOI: 10.1080/13543776.2017.1254195] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
47 Bülbül M, Sinen O, Özkan A, Aslan MA, Ağar A. Central neuropeptide-S treatment improves neurofunctions of 6-OHDA-induced Parkinsonian rats. Exp Neurol 2019;317:78-86. [PMID: 30825442 DOI: 10.1016/j.expneurol.2019.02.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
48 Tobinski AM, Rappeneau V. Role of the Neuropeptide S System in Emotionality, Stress Responsiveness and Addiction-Like Behaviours in Rodents: Relevance to Stress-Related Disorders. Pharmaceuticals (Basel) 2021;14:780. [PMID: 34451877 DOI: 10.3390/ph14080780] [Reference Citation Analysis]
49 Kallupi M, de Guglielmo G, Cannella N, Li HW, Caló G, Guerrini R, Ubaldi M, Renger JJ, Uebele VN, Ciccocioppo R. Hypothalamic neuropeptide S receptor blockade decreases discriminative cue-induced reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 2013;226:347-55. [PMID: 23149909 DOI: 10.1007/s00213-012-2910-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
50 Pałasz A, Rojczyk E. Neuroleptics Affect Neuropeptide S and NPSR mRNA Levels in the Rat Brain. J Mol Neurosci 2015;57:352-7. [PMID: 26227793 DOI: 10.1007/s12031-015-0625-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
51 Dal Ben D, Antonini I, Buccioni M, Lambertucci C, Marucci G, Thomas A, Volpini R, Cristalli G. Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery. ChemMedChem 2011;6:1163-71. [PMID: 21452188 DOI: 10.1002/cmdc.201100038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
52 Patnaik S, Marugan JJ, Liu K, Zheng W, Southall N, Dehdashti SJ, Thorsell A, Heilig M, Bell L, Zook M, Eskay B, Brimacombe KR, Austin CP. Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor. J Med Chem 2013;56:9045-56. [PMID: 24171469 DOI: 10.1021/jm400904m] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
53 Li X, Jiang F, Yao K, Yang L, Gao X, Chen H, Wei X, Wu N, Zhou R, Yuan W, Zhang S. Neuropeptide S attenuates methamphetamine-induced stereotyped behavior in rats. Biochemical and Biophysical Research Communications 2020;527:98-103. [DOI: 10.1016/j.bbrc.2020.04.085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Galesi FL, Ayanwuyi LO, Mijares MG, Cippitelli A, Cannella N, Ciccocioppo R, Ubaldi M. Role of Hypothalamic-Pituitary-Adrenal axis and corticotropin-releasing factor stress system on cue-induced relapse to alcohol seeking. Eur J Pharmacol 2016;788:84-9. [PMID: 27316790 DOI: 10.1016/j.ejphar.2016.06.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
55 Walker LC, Lawrence AJ. The Role of Orexins/Hypocretins in Alcohol Use and Abuse. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 221-46. [DOI: 10.1007/7854_2016_55] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
56 Laas K, Reif A, Akkermann K, Kiive E, Domschke K, Lesch K, Veidebaum T, Harro J. Neuropeptide S receptor gene variant and environment: contribution to alcohol use disorders and alcohol consumption: NPSR1 and alcohol use. Addiction Biology 2015;20:605-16. [DOI: 10.1111/adb.12149] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
57 Kallupi M, Cannella N, Economidou D, Ubaldi M, Ruggeri B, Weiss F, Massi M, Marugan J, Heilig M, Bonnavion P, de Lecea L, Ciccocioppo R. Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system. Proc Natl Acad Sci U S A 2010;107:19567-72. [PMID: 20974945 DOI: 10.1073/pnas.1004100107] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 5.3] [Reference Citation Analysis]
58 Martin-Fardon R, Weiss F. Modeling relapse in animals. Curr Top Behav Neurosci 2013;13:403-32. [PMID: 22389178 DOI: 10.1007/7854_2012_202] [Cited by in Crossref: 7] [Cited by in F6Publishing: 33] [Article Influence: 0.7] [Reference Citation Analysis]
59 Clark SD, Duangdao DM, Schulz S, Zhang L, Liu X, Xu YL, Reinscheid RK. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry. J Comp Neurol 2011;519:1867-93. [PMID: 21452235 DOI: 10.1002/cne.22606] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 7.5] [Reference Citation Analysis]
60 Plaza-Zabala A, Maldonado R, Berrendero F. The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 2012;45:424-39. [PMID: 22430644 DOI: 10.1007/s12035-012-8255-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
61 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
62 Botticelli L, Micioni Di Bonaventura E, Ubaldi M, Ciccocioppo R, Cifani C, Micioni Di Bonaventura MV. The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions. Pharmaceuticals (Basel) 2021;14:293. [PMID: 33810221 DOI: 10.3390/ph14040293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Leonard SK, Ring RH. Immunohistochemical localization of the neuropeptide S receptor in the rat central nervous system. Neuroscience 2011;172:153-63. [PMID: 20950671 DOI: 10.1016/j.neuroscience.2010.10.020] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
64 Ciccocioppo R, Stopponi S, Economidou D, Kuriyama M, Kinoshita H, Heilig M, Roberto M, Weiss F, Teshima K. Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat. Neuropsychopharmacology 2014;39:2601-10. [PMID: 24863033 DOI: 10.1038/npp.2014.113] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
65 Didonet JJ, Cavalcante JC, Souza Lde S, Costa MS, André E, Soares-Rachetti Vde P, Guerrini R, Calo' G, Gavioli EC. Neuropeptide S counteracts 6-OHDA-induced motor deficits in mice. Behav Brain Res 2014;266:29-36. [PMID: 24613977 DOI: 10.1016/j.bbr.2014.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
66 Cannella N, Kallupi M, Ruggeri B, Ciccocioppo R, Ubaldi M. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission. Prog Neurobiol 2013;100:48-59. [PMID: 23041581 DOI: 10.1016/j.pneurobio.2012.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
67 Ghazal P, Ciccocioppo R, Ubaldi M. Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain. Peptides 2013;46:6-12. [PMID: 23684726 DOI: 10.1016/j.peptides.2013.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
68 Ramos SF, Mendonça BP, Leffa DD, Pacheco R, Damiani AP, Hainzenreder G, Petronilho F, Dal-Pizzol F, Guerrini R, Calo' G, Gavioli EC, Boeck CR, de Andrade VM. Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice. Pharmacol Biochem Behav 2012;103:197-203. [PMID: 22960046 DOI: 10.1016/j.pbb.2012.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
69 Schank JR, Ryabinin AE, Giardino WJ, Ciccocioppo R, Heilig M. Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. Neuron 2012;76:192-208. [PMID: 23040815 DOI: 10.1016/j.neuron.2012.09.026] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
70 Tillmann S, Skibdal HE, Christiansen SH, Gøtzsche CR, Hassan M, Mathé AA, Wegener G, Woldbye DPD. Sustained overexpression of neuropeptide S in the amygdala reduces anxiety-like behavior in rats. Behav Brain Res 2019;367:28-34. [PMID: 30914309 DOI: 10.1016/j.bbr.2019.03.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Bossert JM, Marchant NJ, Calu DJ, Shaham Y. The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl). 2013;229:453-476. [PMID: 23685858 DOI: 10.1007/s00213-013-3120-y] [Cited by in Crossref: 284] [Cited by in F6Publishing: 289] [Article Influence: 31.6] [Reference Citation Analysis]
72 González CR, Martínez de Morentin PB, Martínez-Sánchez N, Gómez-Díaz C, Lage R, Varela L, Diéguez C, Nogueiras R, Castaño JP, López M. Hyperthyroidism differentially regulates neuropeptide S system in the rat brain. Brain Res 2012;1450:40-8. [PMID: 22425186 DOI: 10.1016/j.brainres.2012.02.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
73 Guerrini R, Camarda V, Trapella C, Caló G, Rizzi A, Ruzza C, Fiorini S, Marzola E, Reinscheid RK, Regoli D, Salvadori S. Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. J Med Chem 2009;52:4068-71. [PMID: 19473027 DOI: 10.1021/jm900604g] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
74 Anderson RI, Moorman DE, Becker HC. Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol. Handb Exp Pharmacol 2018;248:473-503. [PMID: 29526023 DOI: 10.1007/164_2018_100] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
75 Schmoutz CD, Zhang Y, Runyon SP, Goeders NE. Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats. Pharmacol Biochem Behav 2012;103:332-7. [PMID: 22982682 DOI: 10.1016/j.pbb.2012.09.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]